Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues

Clinical Endocrinology

Volumn 75, Issue 1, 2011, Pages 96-102

  Tzanela, Marinella ^a   Vassiliadi, Dimitra A ^a   Gavalas, Nikolaos ^a   Szabo, Andrea ^a   Margelou, Eleni ^a   Valatsou, Athina ^a   Vassilopoulos, Charalambos ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; ANTIDIABETIC AGENT; INSULIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; GLUCOSE; GLUCOSE BLOOD LEVEL; SOMATOSTATIN;

ACROMEGALY; ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HORMONE DETERMINATION; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; TRANSSPHENOIDAL SURGERY; ANALOGS AND DERIVATIVES; ANALYSIS; BLOOD; COMPARATIVE STUDY; DRUG EFFECTS; HOMEOSTASIS; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ACROMEGALY; BLOOD GLUCOSE; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; SOMATOSTATIN;

EID: 79958785623     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.03996.x     Document Type: Article

References (35)

1. Colao, A., Ferone, D., Marzullo, P., et al. (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews, 25, 102-152. (Pubitemid 38269977)
2. Moller, N., &, Jorgensen, J.O., (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews, 30, 152-177.
3. Kreze, A., Kreze-Spirova, E., &, Mikulecky, M., (2001) Risk factors for glucose intolerance in active acromegaly. Brazilian Journal of Medical and Biological Research, 34, 1429-1433. (Pubitemid 34036845)
4. Clemmons, D.R., Van Wyk, J.J., Ridgway, E.C., et al. (1979) Evaluation of acromegaly by radioimmunoassay of somatomedin-C. New England Journal of Medicine, 301, 1138-1142. (Pubitemid 10158784)
5. Clemmons, D.R., (2002) Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary, 5, 181-183. (Pubitemid 36656431)
6. Kasayama, S., Otsuki, M., Takagi, M., et al. (2000) Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clinical Endocrinology, 52, 549-555. (Pubitemid 30337079)
7. Wright, A.D., Hill, D.M., Lowy, C., et al. (1970) Mortality in acromegaly. Quarterly Journal of Medicine, 39, 1-16.
8. Bates, A.S., Van't Hoff, W., Jones, J.M., et al. (1993) An audit of outcome of treatment in acromegaly. Quarterly Journal of Medicine, 86, 293-299. (Pubitemid 23160830)
9. Etxabe, J., Gaztambide, S., Latorre, P., et al. (1993) Acromegaly: an epidemiological study. Journal of Endocrinological Investigation, 16, 181-187. (Pubitemid 23137956)
10. Rajasoorya, C., Holdaway, I.M., Wrightson, P., et al. (1994) Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology, 41, 95-102. (Pubitemid 24232533)
11. Abosch, A., Tyrrell, J.B., Lamborn, K.R., et al. (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. Journal of Clinical Endocrinology and Metabolism, 83, 3411-3418. (Pubitemid 28500865)
12. Swearingen, B., Barker II, F.G., Katznelson, L., et al. (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3419-3426. (Pubitemid 28500866)
13. Dekkers, O.M., Biermasz, N.R., Pereira, A.M., et al. (2008) Mortality in acromegaly: a metaanalysis. Journal of Clinical Endocrinology and Metabolism, 93, 61-67.
14. Jaffrain-Rea, M.L., Moroni, C., Baldelli, R., et al. (2001) Relationship between blood pressure and glucose tolerance in acromegaly. Clinical Endocrinology, 54, 189-195. (Pubitemid 32193520)
15. Holdaway, I.M., Rajasoorya, R.C., &, Gamble, G.D., (2004) Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 667-674. (Pubitemid 38269875)
16. Moller, N., Schmitz, O., Joorgensen, J.O., et al. (1992) Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. Journal of Clinical Endocrinology and Metabolism, 74, 1012-1019.
17. Sonksen, P.H., Greenwood, F.C., Ellis, J.P., et al. (1967) Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment. Journal of Clinical Endocrinology and Metabolism, 27, 1418-1430.
18. Jaffrain-Rea, M.L., Minniti, G., Moroni, C., et al. (2003) Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. European Journal of Endocrinology, 148, 193-201. (Pubitemid 36305685)
19. Puder, J.J., Nilavar, S., Post, K.D., et al. (2005) Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 90, 1972-1978. (Pubitemid 40590060)
20. Ronchi, C.L., Varca, V., Beck-Peccoz, P., et al. (2006) Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors. Journal of Clinical Endocrinology and Metabolism, 91, 121-128. (Pubitemid 43069127)
21. Giustina, A., Chanson, P., Bronstein, M.D., et al. (2010) A consensus on criteria for cure of acromegaly. Journal of Clinical Endocrinology and Metabolism, 95, 3141-3148.
22. Strowski, M.Z., Parmar, R.M., Blake, A.D., et al. (2000) Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology, 141, 111-117. (Pubitemid 32260349)
23. Verschoor, L., Lamberts, S.W., Uitterlinden, P., et al. (1986) Glucose tolerance during long term treatment with a somatostatin analogue. British Medical Journal (Clinical Research ed.), 293, 1327-1328. (Pubitemid 17181792)
24. Steffin, B., Gutt, B., Bidlingmaier, M., et al. (2006) Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly. European Journal of Endocrinology, 155, 73-78. (Pubitemid 44103377)
25. Mazziotti, G., Floriani, I., Bonadonna, S., et al. (2009) Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. Journal of Clinical Endocrinology and Metabolism, 94, 1500-1508.
26. Giustina, A., Barkan, A., Casanueva, F.F., et al. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526-529. (Pubitemid 32273628)
27. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. (Pubitemid 15018832)
28. Stumvoll, M., Mitrakou, A., Pimenta, W., et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care, 23, 295-301. (Pubitemid 30131733)
29. Ho, K.K., Jenkins, A.B., Furler, S.M., et al. (1992) Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly. Clinical Endocrinology, 36, 271-279.
30. Rizza, R.A., Mandarino, L.J., Genest, J., et al. (1985) Production of insulin resistance by hyperinsulinaemia in man. Diabetologia, 28, 70-75. (Pubitemid 15128811)
31. Singh, V., Brendel, M.D., Zacharias, S., et al. (2007) Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. Journal of Clinical Endocrinology and Metabolism, 92, 673-680.
32. Arosio, M., Macchelli, S., Rossi, C.M., et al. (1995) Effects of treatment with octreotide in acromegalic patients-a multicenter Italian study. Italian Multicenter Octreotide Study Group. European Journal of Endocrinology, 133, 430-439.
33. Jorgensen, J.O., Feldt-Rasmussen, U., Frystyk, J., et al. (2005) Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist. Journal of Clinical Endocrinology and Metabolism, 90, 5627-5631. (Pubitemid 41415468)
34. Barkan, A.L., Burman, P., Clemmons, D.R., et al. (2005) Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant. Journal of Clinical Endocrinology and Metabolism, 90, 5684-5691. (Pubitemid 41415476)
35. Colao, A., Auriemma, R.S., Galdiero, M., et al. (2009) Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. Journal of Clinical Endocrinology and Metabolism, 94, 528-537.